Author

Wei Wang

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Heterogeneity of folate receptor alpha expression and associations with molecular biomarker in ovarian high-grade serous carcinoma: A multicenter Chinese cohort study.

BACKGROUND Folate receptor alpha (FRα) is an established therapeutic target in ovarian cancer, but information on its expression distribution, staining heterogeneity, and molecular context in Chinese patients remains limited. We evaluated these features in ovarian high grade serous carcinoma (HGSC). METHODS This retr...

Fei-Fei Li, Dan-Hui Li, Yun Xi et al. · Gynecologic Oncology · 0 citations

Open access Sep 2026

Survival trends and prognostic factors of metastatic cervical cancer: a population-based cohort study

Background Metastatic cervical cancer (mCC) remains a highly lethal disease. While clinical trials support the addition of targeted therapy and immunotherapy to chemotherapy, real-world survival trends are less well characterized. This study aimed to evaluate real-world overall survival trends and prognostic factors in...

Cheng Wang, Cai-Hou Xu, Xing-Chen He et al. · Gynecology and Pelvic Medici... · 0 citations

Open access Aug 2026

NUSAP1 Is a Potential Diagnostic Biomarker for High-Grade Endometrial Stromal Sarcoma: An Integrated Machine Learning and Clinical Validation Study

Findings indicate that NUSAP1 is a novel immunohistochemical marker with high specificity that can serve as an important complement to existing markers such as Cyclin D1 and BCOR, providing a new practical tool for the precise pathological diagnosis of HGESS.

Cheng Wang, Yuling Kou, Jing Zeng et al. · Archives of Pathology &... · 0 citations